High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program

Joseph R. Mikhael, Andrew R. Belch, H. Miles Prince, Maria Nambo Lucio, Angelo Maiolino, Alessandro Corso, Maria Teresa Petrucci, Pellegrino Musto, Mieczyslaw Komarnicki, A. Keith Stewart

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program'. Together they form a unique fingerprint.

Medicine & Life Sciences